A detailed history of Johnson & Johnson transactions in Meira G Tx Holdings PLC stock. As of the latest transaction made, Johnson & Johnson holds 6,641,064 shares of MGTX stock, worth $41.7 Million. This represents 8.83% of its overall portfolio holdings.

Number of Shares
6,641,064
Previous 6,641,064 -0.0%
Holding current value
$41.7 Million
Previous $28 Million 0.95%
% of portfolio
8.83%
Previous 9.66%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

BUY
$5.8 - $8.98 $21.7 Million - $33.6 Million
3,742,514 Added 129.12%
6,641,064 $43.3 Million
Q3 2021

Nov 12, 2021

BUY
$11.73 - $16.08 $34 Million - $46.6 Million
2,898,550 New
2,898,550 $38.2 Million

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $283M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Johnson & Johnson Portfolio

Follow Johnson & Johnson and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson & Johnson, based on Form 13F filings with the SEC.

News

Stay updated on Johnson & Johnson with notifications on news.